Approach to haemolytic anaemia (investigation)
haemolysis work-up · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A structured framework for confirming haemolysis and localising the cause as immune or non-immune, inherited or acquired, intravascular or extravascular, guiding targeted testing and urgent recognition of microangiopathy.
Red flags
- Schistocytes with thrombocytopenia (TTP/HUS - emergency)
- Haemoglobinuria with acute kidney injury
- Rapidly falling haemoglobin
- Fever with haemolysis (malaria, sepsis)
- Neurological signs with thrombocytopenia
Assessment
Differential diagnosis
- Autoimmune haemolytic anaemia
- Microangiopathic (TTP/HUS/DIC)
- Hereditary membrane/enzyme defects (spherocytosis, G6PD)
- Haemoglobinopathy (sickle, thalassaemia)
- Mechanical (prosthetic valve)
- Infection (malaria) or drug-induced
Investigations
- FBC, reticulocyte count, blood film (key: schistocytes, spherocytes, bite cells)
- LDH (raised), haptoglobin (low), unconjugated bilirubin (raised)
- Direct antiglobulin test
- Urinalysis for haemoglobinuria / urinary haemosiderin (intravascular)
- G6PD assay, osmotic fragility/EMA binding, haemoglobin electrophoresis as directed
- Blood cultures/malaria film and coagulation screen if indicated
Management
- Confirm haemolysis: high reticulocytes, high LDH, low haptoglobin, raised unconjugated bilirubin
- Examine the film first - schistocytes mandate urgent microangiopathy work-up
- Check the DAT: positive implies immune haemolysis; negative points to non-immune causes
- Distinguish intravascular (haemoglobinuria, very high LDH, very low haptoglobin) from extravascular
- If DAT negative, pursue inherited causes: membrane, enzyme, haemoglobinopathy testing
- Consider PNH testing (flow cytometry) if DAT negative with thrombosis or cytopenias
- Review drugs, infections and mechanical causes
- If schistocytes with thrombocytopenia, treat as a thrombotic microangiopathy emergency until excluded
- Direct definitive management to the identified mechanism
Drugs & doses
Folic acid 5 mg PO daily (supportive in chronic haemolysis)
No specific drug until mechanism defined; treat underlying cause
Disposition
Depends on cause; urgent haematology/critical care if microangiopathy suspected; outpatient work-up for stable chronic haemolysis.
Complications & pitfalls
- Missed TTP leading to death if untreated
- Pigment nephropathy from intravascular haemolysis
- Gallstones in chronic haemolysis
- Aplastic crisis (parvovirus) in chronic haemolytic states
- Iron overload with repeated transfusion
Exam pearls
- The blood film is the single most informative test in haemolysis
- Schistocytes plus low platelets = think TTP and act fast
- A negative DAT does not exclude immune haemolysis entirely but redirects to inherited causes
- Low haptoglobin plus high LDH plus high reticulocytes is the classic triad
- Urinary haemosiderin indicates chronic intravascular haemolysis
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.